Bill Summary for S 321 (2021-2022)

Summary date: 

Apr 1 2021

Bill Information:

View NCGA Bill Details2021
Senate Bill 321 (Public) Filed Thursday, March 18, 2021
Intro. by McInnis, Lazzara, Edwards.

View: All Summaries for BillTracking:

Bill summary

Senate amendment to the 1st edition adds the following.

Modifies anticonvulsants, classified as a Class V controlled substance under GS 90-93, to specify that the term includes cenobamate and lasmiditan and their salts, isomers, and salts of isomers, unless specifically exempted or excluded or unless listed in another schedule.


© 2021 School of Government The University of North Carolina at Chapel Hill

This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.

Printer-friendly: Click to view